October 6, 2022in Blogs, IP, Patents, Pharmaceutical Drugs0by Editor934 Another Win for BMS and Pfizer’s APIXABAN Patents Pankhuri Malik is an IPilogue Writer, IP Innovation Clinic Fellow, and an LLM Candidate at Osgoode Hall Law School. On August 04, 2022, the Federal Court of Appeal (“FCA”) reaffirmed…
